BioCardia, Inc. financial data

Symbol
BCDA on Nasdaq
Location
Sunnyvale, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 82.8 % +29.3%
Debt-to-equity 24.3K %
Return On Equity -58.9K % -5984%
Return On Assets -242 % -16%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.6M shares +132%
Common Stock, Shares, Outstanding 10.6M shares +135%
Entity Public Float 5.6M USD -88.3%
Common Stock, Value, Issued 11K USD +120%
Weighted Average Number of Shares Outstanding, Basic 6.28M shares +122%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 5.25M USD +27.2%
Costs and Expenses 8.59M USD +9.59%
Operating Income (Loss) -8.59M USD -10.6%
Nonoperating Income (Expense) 46K USD +9.52%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -8.54M USD -10.6%
Earnings Per Share, Basic -1 USD/shares +80.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.29M USD +7.24%
Accounts Receivable, after Allowance for Credit Loss, Current 10K USD 0%
Assets, Current 5.37M USD +6.11%
Property, Plant and Equipment, Net 13K USD -72.3%
Operating Lease, Right-of-Use Asset 599K USD -39.7%
Other Assets, Noncurrent 171K USD 0%
Assets 6.15M USD -1.9%
Accounts Payable, Current 1.08M USD +89.8%
Accrued Liabilities, Current 108K USD +286%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 3.31M USD +16.5%
Operating Lease, Liability, Noncurrent 211K USD -68.7%
Liabilities 3.52M USD +0.2%
Retained Earnings (Accumulated Deficit) -166M USD -5.41%
Stockholders' Equity Attributable to Parent 2.63M USD -4.58%
Liabilities and Equity 6.15M USD -1.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.62M USD -5.75%
Net Cash Provided by (Used in) Financing Activities 196K USD -85.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 10.6M shares +135%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.42M USD -823%
Deferred Tax Assets, Valuation Allowance 38.5M USD +4.86%
Deferred Tax Assets, Gross 38.5M USD +4.86%
Operating Lease, Liability 638K USD -38.9%
Depreciation 36K USD -50%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 683K USD -42%
Property, Plant and Equipment, Gross 795K USD +0.25%
Operating Lease, Liability, Current 427K USD +15.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 514K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 125K USD -75%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 45K USD -66.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 44K USD 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 1.78M USD +5.84%
Lessee, Operating Lease, Liability, to be Paid, Year Four 44K USD -91.4%
Operating Lease, Payments 375K USD +15%
Additional Paid in Capital 169M USD +5.24%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 12K USD -36.8%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 521K USD -30.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%